Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO

ClinicalTrials.gov ID: NCT01465802

Public ClinicalTrials.gov record NCT01465802. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 10:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ARCHER 1042: A PHASE 2 STUDY OF DACOMITINIB IN ADVANCED NON-SMALL CELL LUNG CANCER (POST-CHEMOTHERAPY OR SELECT FIRST LINE PATIENTS) TO EVALUATE PROPHYLACTIC INTERVENTION ON DERMATOLOGIC AND GASTROINTESTINAL ADVERSE EVENTS AND PATIENT REPORTED OUTCOMES

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To assess the impact of prophylactic treatment on the incidence of adverse events in advanced NSCLC patients (post chemotherapy) treated with dacomitinib daily as a single agent. To assess the impact of an interrupted dacomitinib dosing schedule in Cycle 1 on the incidence of adverse events in first-line advanced NSCLC patients with an EGFR mutation (HER-1 mutation, HER-2 mutation or HER-2 amplification).

Study identification

NCT ID
NCT01465802
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
236 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 25, 2011
Primary completion
May 17, 2015
Completion
May 17, 2015
Last update posted
Jan 8, 2019

2011 – 2015

United States locations

U.S. sites
79
U.S. states
20
U.S. cities
52
Facility City State ZIP Site status
City of Hope Duarte California 91010
St. Jude Heritage Healthcare Fullerton California 92835
UCLA Hematology Oncology Irvine California 92604
UC San Diego Medical Center - La Jolla La Jolla California 92037
UC San Diego Moores Cancer Center - Investigational Drug Services La Jolla California 92037
UC San Diego Moores Cancer Center La Jolla California 92093
Drug Management Only: UCLA West Medical Pharmacy Los Angeles California 90095-7349
Drug Management Only: UCLA West Medical Pharmacy Attn: Steven L. Wong, Pharm.D. Los Angeles California 90095
Drug Management Only: UCLA West Medical Pharmacy Los Angeles California 90095
Drug Managment Only: UCLA West Medical Pharmacy Los Angeles California 90095
Regulatory Management Only TRIO-US Central Administration Los Angeles California 90095
Regulatory Management Only: TRIO-US Central Administration Los Angeles California 90095
Ronald Reagan UCLA Medical Center Los Angeles California 90095
UCLA Hematology Oncology Los Angeles California 90095
Westwood Bowyer Clinic Los Angeles California 90095
UCLA/Pasadena HealthCare Pasadena California 91105
UC San Diego Medical Center - Hillcrest San Diego California 92103
Coastal Integrative Cancer Care San Luis Obispo California 93401
SANSUM Clinic Santa Barbara California 93105
Cancer Center of Santa Barbara with SANSUM Clinic Santa Barbara California 93150
Central Coast Medical Oncology Corporation Santa Maria California 93454
UCLA Hematology Oncology Santa Monica California 90404
UCLA Santa Monica Medical Center & Orthopaedic Hospital Santa Monica California 90404
Cancer Center of Santa Barbara with SANSUM Clinic Solvang California 93463
City of Hope South Pasadena Cancer Center South Pasadena California 91030
UCLA/Santa Clarita Valley Cancer Center Valencia California 91355
UCLA Cancer Center Westlake Village California 91361
Kaiser Permanente Colorado - Franklin Denver Colorado 80205
St. Mary's Hospital Regional Cancer Center Grand Junction Colorado 81501
Kaiser Permanente Colorado - Rock Creek Lafayette Colorado 80026
Kaiser Permanente Colorado - Lonetree Lonetree Colorado 80124
Michael and Dianne Bienes Comprehensive Cancer Center, Holy Cross Hospital Fort Lauderdale Florida 33308
Memorial Cancer Institute Hollywood Florida 33021
Cancer Care of North Florida, PA Lake City Florida 32024
Memorial West Cancer Institute Pembroke Pines Florida 33028
University Cancer & Blood Center, LLC Athens Georgia 30607
Summit Cancer Care,PC Savannah Georgia 31404
Summit Cancer Care, PC Savannah Georgia 31405
Rush University Medical Center, Division of Hematology & Oncology Chicago Illinois 60612
Ships Drugs to: Emmanuel Semmes, RPh (or Ami Patel, Pharm D) University of Chicago Chicago Illinois 60637
University of Chicago Medical Center Chicago Illinois 60637
Illinois CancerCare, P.C. Peoria Illinois 61615
Cancer Center of Kansas Wichita Kansas 67208
Cancer Center of Kansas Wichita Kansas 67214
Josephine Ford Cancer Center-Downriver Brownstown Michigan 48183
Henry Ford Medical Center - Fairlane Dearborn Michigan 48126
Henry Ford Hospital Detroit Michigan 48202
Henry Ford Medical Center - Columbus Novi Michigan 48377
Henry Ford Hospital and Medical Center - West Bloomfield West Bloomfield Michigan 48322
The West Clinic, PC Corinth Mississippi 38834
The West Clinic, PC Southaven Mississippi 38671
Mercy Clinic Cancer & Hematology-Branson Branson Missouri 65616
Mercy Hospital Springfield Springfield Missouri 65804
Mercy Clinic Cancer and Hematology - Chub O-Reilly Cancer Center Springfield Missouri 65807
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89128
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169
Saint Barnabas Medical Center Livingston New Jersey 07039
Beth Israel Medical Center New York New York 10003
Beth Israel Comprehensive Cancer Center New York New York 10011
Columbia University Medical Center - The New York Presbyterian Hospital New York New York 10032
Stony Brook University Medical Center-Cancer Center Stony Brook New York 11794-9447
Montefiore-Einstein Center for Cancer Care The Bronx New York 10461
Montefiore Medical Center The Bronx New York 10467
Carolina Oncology Specialists, PA Hickory North Carolina 28602
Wake Forest University Health Sciences Winston-Salem North Carolina 27157
Legacy Pharma Research Bismarck North Dakota 58501
Mid Dakota Clinic, PC Bismarck North Dakota 58501
St Alexius Medical Center Bismarck North Dakota 58501
Charleston Hematology Oncology Associates, PA Charleston South Carolina 29414
The West Clinic, PC Memphis Tennessee 38104
The West Clinic, PC Memphis Tennessee 38120
Investigational Product Center (IPC) Fort Worth Texas 76177
Investigational Products Center (IPC) Fort Worth Texas 76177
'Fletcher Allen Health Care, Inc Burlington Vermont 05401
Office of Clinical Trials Research, Fletcher Allen Health Care, Inc. Burlington Vermont 05405
Virginia Cancer Specialists, PC Fairfax Virginia 22031
Swedish Cancer Institute - Issaquah Issaquah Washington 98029
Swedish Cancer Institute Seattle Washington 98104
Swedish Medical Center Seattle Washington 98122

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01465802, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 8, 2019 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01465802 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →